Presentation by Primary Information Services www.primaryinfo.com mailto:primaryinfo@gmail.com

1. Voglibose
Presentation by
Primary Information Services
www.primaryinfo.com
mailto:primaryinfo@gmail.com

2. Voglibose is categorized as an α glucosidase
inhibitors, it was discovered in Japan in 1981 when
it was isolated from the culture media producing
Streptomyces hygroscopicity var.
• limonons and was commercially available since
1995 for the treatment of postprandial
hyperglycemia.
• It exerts an anti-hypoglycemic action from a
reversible inhibition of the membrane-bound
intestinal enzyme α glycosidase hydrolyze and
prevents the increase in blood glucose level
post-meal.

4. Database Offer:
Manufacturing Process
Route of Synthesis
Process Flow Diagram
Input and output and mass Balance
Pollution load
Solvent Balance of Voglibose
Raw Materials
Patents, COA, MSDS, SDS

7. Market Players:
Eris
Life Care
Sarian
Pfizer Limited
Blue Cross
AS Pharma
Neelkanth Healthcare (P)Ltd
Strides
Three Dots Lifesciences
Nexus Biotech
Panacea Biotec Ltd
Unichem